You are not currently logged in.
Access JSTOR through your library or other institution:
Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid β Aggregation
Jason E. Gestwicki, Gerald R. Crabtree and Isabella A. Graef
New Series, Vol. 306, No. 5697 (Oct. 29, 2004), pp. 865-869
Published by: American Association for the Advancement of Science
Stable URL: http://www.jstor.org/stable/3839541
Page Count: 5
You can always find the topics here!Topics: Aggregation, Neurons, Molecules, Solar fibrils, Alzheimers disease, Cell aggregates, Toxicity, Amyloids, Drug interactions, Medical treatment
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Protein aggregation is involved in the pathogenesis of neurodegenerative diseases and hence is considered an attractive target for therapeutic intervention. However, protein-protein interactions are exceedingly difficult to inhibit. Small molecules lack sufficient steric bulk to prevent interactions between large peptide surfaces. To yield potent inhibitors of β-amyloid (Aβ) aggregation, we synthesized small molecules that increase their steric bulk by binding to chaperones but also have a moiety available for interaction with Aβ. This strategy yields potent inhibitors of Aβ aggregation and could lead to therapeutics for Alzheimer's disease and other forms of neurodegeneration.
Science © 2004 American Association for the Advancement of Science